Manhattan Scientifics, Inc.

MHTX

US5631221000

Entertainment Production

Market Closed - OTC Markets Other stock markets 01:35:17 2024-04-26 pm EDT			5-day change	1st Jan Change
0.00165 ^USD	+37.50%		0.00%	-34.62%

Apr. 10	Manhattan Scientifics, Inc Announces Resignation of Frank Georgiou as Member of the Board of Directors	CI
Apr. 02	Manhattan Scientifics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Manhattan Scientifics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022

May 16, 2022 at 06:09 am EDT

Manhattan Scientifics, Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported net loss was USD 0.647 million compared to net income of USD 0.134 million a year ago.

Latest news about Manhattan Scientifics, Inc.

Manhattan Scientifics, Inc Announces Resignation of Frank Georgiou as Member of the Board of Directors	Apr. 10	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 02	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 20	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-21	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-22	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-13	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-06	CI
Manhattan Scientifics, Inc. Auditor Raises 'Going Concern' Doubt	22-04-05	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-23	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-17	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-15	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-16	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-19	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-20	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-14	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-19	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-19	CI
Manhattan Scientifics Announces Breakthrough Device for Detection of Cancer	19-07-18	CI
Manhattan Scientifics To Seek Acquisition	19-07-09	CI
Manhattan Scientifics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-20	CI
Manhattan Scientifics, Inc., and Metallicum, Inc. Enters into an Overarching Agreement with a Non-Affiliated Third Party	19-05-07	CI

Chart Manhattan Scientifics, Inc.

Duration

Period

More charts

Company Profile

Manhattan Scientifics, Inc. is focused on technology transfer and commercialization of these transformative technologies. The Company operates as a technology incubator. Its business model is to identify significant technologies; acquire them or the rights to them; secure the services of inventors, engineers or other staff who were instrumental in their creation; provide or contract for suitable work facilities, laboratories, and other aids where appropriate; prototype the technologies to demonstrate proof of principle feasibility; secure patent and or other intellectual property protection; secure early customers for product trials where feasible and appropriate; and commercialize through licenses, sales or cooperative efforts with other manufacturing and distribution firms. Its business model is based on licensing metals technology to metals manufacturers. Its technologies are in a development phase.

Sector

Entertainment Production

More about the company

Income Statement Evolution

More financial data

Sector Copyright Management

	1st Jan change	Capi.
MANHATTAN SCIENTIFICS, INC.	-34.62%	923K
FRANCHISE BRANDS PLC	+25.08%	483M
DIVERSIFIED ROYALTY CORP.	+1.83%	334M
B.DUCK SEMK HOLDINGS INTERNATIONAL LIMITED	-10.69%	147M
QANTM INTELLECTUAL PROPERTY LIMITED	+61.58%	140M
PENDRELL CORPORATION	-.--%	139M
KUKE MUSIC HOLDING LIMITED	+142.88%	95.63M
NEXTONE INC.	-2.80%	73.01M
RESEARCH FRONTIERS INCORPORATED	+57.43%	53.28M